только у нас скачать шаблон dle скачивать рекомендуем
» » Papillomavirus vaccine can effectively fight cancer

Papillomavirus vaccine can effectively fight cancer

It has long been proven that the papillomavirus is one of the main causes of cancer in various forms, both women and men. The most famous are the outward sign of disease warts -. Cutaneous, genital, etc. Infection with this virus occurs during sexual intercourse, and for a long time, it can not be shown. Therefore, the presence of warts should be a serious cause for a thorough examination, and leading Israeli clinics have everything you need for this.

The extent of the disease is difficult to assess papilloma, again because of the significant delay display outward signs. Judging of precancerous changes in the cervix, in the same Israel is recorded about 1,000 such cases annually, and one fifth of them cause cancer. Among the surveyed patients annually is possible to ascertain the presence of genital warts in about 20 000 people (sexually active) - and a large part of them eventually received a diagnosis of "cancer" of the different organs of the urogenital system.

It is important that even the condom protects only partially against HPV. Touching any parts of the skin, at least at the abdomen or pubic hair, can already cause infection. Therefore, a regular medical examination in clinics, which are needed for the treatment of papillomavirus vaccine is strongly recommended. Currently, two types of vaccine is widely used - Cervarix (GlaxoSmithKline) and Gardasil (Merck), approved by Ministry of Health of Israel. They contain an empty shell of the virus, without DNA. The introduction of such a shell in the body contributes to the development of immunity. The difference between the vaccines is that they are designed for different strains - and there is a total of about a hundred. Cervarix is ??intended for both men and women, Gardasil for women only. The duration of action of the vaccine is approximately 15 years.
Information
Users of Гости are not allowed to comment this publication.